Literature DB >> 379331

Ames test of 1-(X-phenyl)-3,3-dialkyltriazenes. A quantitative structure-activity study.

B H Venger, C Hansch, G J Hatheway, Y U Amrein.   

Abstract

The mutagenicity of 1-(X-phenyl)-3,3-dialkyltriazenes was tested in the Ames test using Salmonella typhimurium TA92. The following quantitative structure-activity relationship (QSAR) was formulated: log 1/C = 1.09 log P -1.63 sigma+ + 5.58. In this expression, C is the molar concentration of triazene producing 30 mutations/10(8) bacteria above background. This equation is based on 17 congeners and has a correlation coefficient of 0.974. The QSAR for mutagenicity is compared with QSAR for antileukemia action and toxicity (LD50) in mice. The mutagenicity of aflatoxin B (log 1/C = 9.5) and DTIC (log 1/C = 3.0) have also been determined.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 379331     DOI: 10.1021/jm00191a003

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  4 in total

Review 1.  Quantitative structure-activity relationships (QSAR) and molecular modelling in cancer research.

Authors:  H Kubinyi
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

2.  Quantitative structure-activity relationships of mutagenic activity from quantum topological descriptors: triazenes and halogenated hydroxyfuranones (mutagen-X) derivatives.

Authors:  P L A Popelier; P J Smith; U A Chaudry
Journal:  J Comput Aided Mol Des       Date:  2004-11       Impact factor: 3.686

3.  Effects of an inducer and an inhibitor of hepatic metabolism on the antitumor action of dimethyltriazenes.

Authors:  G Sava; S Zorzet; L Perissin; T Giraldi; L Lassiani
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

4.  Immunogenic changes of murine lymphoma cells following in vitro treatment with aryl-triazene derivatives.

Authors:  B Nardelli; A R Contessa; L Romani; G Sava; C Nisi; M C Fioretti
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.